Delivery Order SPE2DB20D3505-SPE2DB23FT7U0
Award Date 2/28/23
Potential Completion Date 3/1/23
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of the pharmaceutical product Restasis 0.05% eye emulsion, with a ceiling value of $1,529.98 and a completion date of July 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Restasis 0.05% eye emulsion, a specialty medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,406.73 and a completion date of November 1, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Restasis 0.05% eye emulsion, a prescription medication used to treat dry eye disease. The contract has a ceiling value of $2,860.07 and a period of performance through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The contract has a ceiling value of $71,009.21 and an ultimate completion date of February 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,695.65, is for the delivery of Restasis 0.05% Eye Emulsion in 60-count packs. The contract has a firm fixed-price pricing type and an ultimate completion date of December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,837.22, is for the supply of Restasis 0.05% Eye Emulsion 30S, a prescription eye medication. The contract has a completion date of July 18, 2022 and is a Firm Fixed Price agreement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Restasis 0.05% eye emulsion, a prescription eye medication. The contract has a ceiling value of $4,622.08 and a completion date of May 5, 2023. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, to support federal healthcare programs. The contract has a ceiling value of $2,678.62 and a period of performance through January 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of RESTASIS 0.05% eye emulsion, a prescription medication. The contract has a firm fixed price of $7,424.70 and a completion date of June 24, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The contract has a ceiling value of $4,748.43 and a period of performance ending on September 4, 2024. It is a firm-fixed-price contract. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up...